FRIDAY, Jan. 11 (HealthDay News) -- The U.S. Food and Drug Administration said it's approved 14 new tests for determining a person's blood type, a process that's essential to a safe blood supply and safe transfusions.
Mismatched transfused blood can cause serious, potentially fatal reactions.
"These 14 new tests will provide blood establishments and transfusion services with additional choices to help assure safe, well-matched transfusions," Dr. Jesse L. Goodman, director of the FDA's Center for Biologics Evaluation and Research, said in a prepared statement. "The tests offer a broader diversity of reliable blood-typing tests and will help protect against product shortages."
The Olympus PK System Blood Group and Phenotyping Reagents use monoclonal antibodies to test for the A, B, O and Rh factors, as well as for other factors that signify rarer blood types.
The tests are manufactured by a French company, DIAGAST.
More information
The American Red Cross has more information about blood types.
Email To A Friend
